ISHARES TR's ticker is HDV and the CUSIP is 46429B663. A total of 365 filers reported holding ISHARES TR in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,238 | -5.9% | 63,080 | -4.1% | 0.04% | -7.3% |
| Q2 2023 | $6,628 | +4.1% | 65,764 | +5.0% | 0.04% | -4.7% |
| Q1 2023 | $6,367 | +12.7% | 62,631 | +15.5% | 0.04% | +2.4% |
| Q4 2022 | $5,651 | -100.0% | 54,215 | -95.5% | 0.04% | -95.2% |
| Q3 2022 | $109,957,000 | -8.8% | 1,204,480 | +0.4% | 0.87% | -6.5% |
| Q2 2022 | $120,507,000 | +5476.4% | 1,199,908 | +5835.4% | 0.93% | +6126.7% |
| Q1 2022 | $2,161,000 | +27.9% | 20,216 | +20.8% | 0.02% | +25.0% |
| Q4 2021 | $1,689,000 | +25.7% | 16,729 | +20.2% | 0.01% | +9.1% |
| Q2 2021 | $1,344,000 | 0.0% | 13,919 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $1,344,000 | 0.0% | 13,919 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $1,344,000 | 0.0% | 13,919 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $1,344,000 | 0.0% | 13,919 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $1,344,000 | 0.0% | 13,919 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $1,344,000 | 0.0% | 13,919 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $1,344,000 | 0.0% | 13,919 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $1,344,000 | 0.0% | 13,919 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $1,344,000 | 0.0% | 13,919 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $1,344,000 | -62.3% | 13,919 | -67.1% | 0.01% | -87.6% |
| Q4 2018 | $3,565,000 | -0.4% | 42,249 | +6.8% | 0.09% | -2.2% |
| Q3 2018 | $3,581,000 | +10.6% | 39,551 | +3.8% | 0.09% | -15.0% |
| Q2 2018 | $3,237,000 | -0.5% | 38,092 | -1.1% | 0.11% | -17.1% |
| Q1 2018 | $3,254,000 | -4.6% | 38,516 | +1.8% | 0.13% | -15.1% |
| Q4 2017 | $3,412,000 | +4.7% | 37,853 | -0.2% | 0.15% | -1.3% |
| Q3 2017 | $3,260,000 | +7.9% | 37,924 | +4.4% | 0.15% | -0.6% |
| Q2 2017 | $3,021,000 | -3.7% | 36,341 | -2.8% | 0.16% | -12.4% |
| Q1 2017 | $3,136,000 | +4.0% | 37,390 | +2.0% | 0.18% | -4.3% |
| Q4 2016 | $3,015,000 | -2.1% | 36,658 | -3.3% | 0.18% | -13.1% |
| Q3 2016 | $3,080,000 | +4.9% | 37,897 | +6.0% | 0.21% | -0.5% |
| Q2 2016 | $2,937,000 | +22.2% | 35,753 | +16.0% | 0.21% | +1.4% |
| Q1 2016 | $2,404,000 | – | 30,813 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVS HEALTH Corp | 624,536 | $62,722,000 | 52.01% |
| Angeles Investment Advisors, LLC | 2,162,920 | $217,222,000 | 19.86% |
| Bull Oak Capital, LLC | 162,500 | $16,320,000 | 15.09% |
| Essex Private Wealth Management, LLC | 38,182 | $3,835,000 | 14.33% |
| VAUGHAN & Co SECURITIES, INC. | 145,498 | $14,612,000 | 11.71% |
| SWISS RE LTD | 564,820 | $56,725,000 | 11.35% |
| Rain Capital Management, LLC | 133,852 | $13,443,000 | 9.66% |
| Titus Wealth Management | 189,826 | $19,064,000 | 9.55% |
| MCIA Inc | 182,506 | $18,400,000 | 9.20% |
| Prostatis Group LLC | 55,911 | $5,615,175 | 8.75% |